Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

31.07
Delayed Data
As of Nov 21
 +0.25 / +0.81%
Today’s Change
25.25
Today|||52-Week Range
36.82
+8.90%
Year-to-Date
Company News For Nov 21, 2017
Nov 21 / Zacks.com - Paid Partner Content
Novartis (NVS) Arm's Biosimilars Study Results Encourage
Nov 14 / Zacks.com - Paid Partner Content
Roche Reports Positive Data From Tecentriq Combination Study
Nov 20 / Zacks.com - Paid Partner Content
Nektar/Bristol-Myers' Combo Trial Positive in Phase I/II
Nov 13 / Zacks.com - Paid Partner Content
Foreign Stock Roundup: JD.com Beats Estimates, Petrobras & Infineon Miss
Nov 20 / Zacks.com - Paid Partner Content
Amgen Gets Positive CHMP Opinion to Expand Nplate's Label
Nov 13 / Zacks.com - Paid Partner Content
Roche Stock Surges on Trial Successes in Cancer, Haemophilia
Nov 20 / TheStreet.com - Paid Partner Content
Merck KGaA (MKGAF) Q3 Earnings Decline Y/Y, Revenues Flat
Nov 10 / Zacks.com - Paid Partner Content
Pfizer's Cancer Drug Sutent Gets FDA Nod for Label Expansion
Nov 17 / Zacks.com - Paid Partner Content
Puma (PBYI) Falls Despite Narrower-Than-Expected Q3 Loss
Nov 10 / Zacks.com - Paid Partner Content
Cancer Space Update: Label Expansion for Three Major Drugs
Nov 17 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod
Nov 10 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Hemophilia A Drug Receives FDA Approval
Nov 17 / Zacks.com - Paid Partner Content
Inovio (INO) Q3 Loss Wider Than Expected, Revenues Miss
Nov 09 / Zacks.com - Paid Partner Content
Why is Alnylam's (ALNY) Stock Up More Than 200% this Year?
Nov 16 / Zacks.com - Paid Partner Content
Ophthotech (OPHT) Q3 Earnings & Sales Beat, Zimura in Focus
Nov 09 / Zacks.com - Paid Partner Content
Roche (RHHBY) Receives FDA Clearance for Ventana MMR Test
Nov 15 / Zacks.com - Paid Partner Content
Nektar (NKTR) Q3 Earnings & Sales Surpass, Sales View Up
Nov 08 / Zacks.com - Paid Partner Content
Shire Gets Positive CHMP Opinion for Hemophilia A Drug
Nov 14 / Zacks.com - Paid Partner Content
Prothena (PRTA) Earnings Beat in Q3, Pipeline in Focus
Nov 08 / Zacks.com - Paid Partner Content